Aspirin Resistance in Cardiovascular Disease: A Review-Reference-Cited by-同舟云学术

Aspirin Resistance in Cardiovascular Disease: A Review

Published:2004-05 Issue:5 Volume:27 Page:456-465
ISSN:1078-5884
Container-title:European Journal of Vascular and Endovascular Surgery
language:en
Short-container-title:European Journal of Vascular and Endovascular Surgery

Author:

Wong S,Appleberg M,Ward C.M,Lewis D.R

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Surgery

Reference60 articles.

1. Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy;Alexander;Am J Cardiol,1999

2. Profile and prevalence of aspirin resistance in patients with cardiovascular disease;Gum;Am J Cardiol,2001

3. Preliminary report. Findings from the aspirin component of the ongoing Physicians' Health Study;N Engl J Med,1988

4. Final report on the aspirin component of the ongoing Physicians' Health Study;N Engl J Med,1989

5. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2;Lancet,1988

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of hyperuricemia in people taking low-dose aspirin using a machine learning algorithm: a cross-sectional study of the National Health and Nutrition Examination Survey;Frontiers in Pharmacology;2024-01-19

2. Identification of the Antithrombotic Mechanism of Leonurine in Adrenalin Hydrochloride-Induced Thrombosis in Zebrafish via Regulating Oxidative Stress and Coagulation Cascade;Frontiers in Pharmacology;2021-11-04

3. The Pre- and Postoperative Prevalence and Risk Factors of ASA Nonresponse in Vascular Surgery;Clinical and Applied Thrombosis/Hemostasis;2021-01

4. Cardiovascular Risk Reduction;Critical Care Nursing Clinics of North America;2019-03

5. Aspirin in childhood acute ischemic stroke: The evidence for treatment and efficacy testing;Pediatric Blood & Cancer;2019-02-14